BACKGROUND: Transfusion-related acute lung injury (TRALI) is the leading cause of transfusion-related death in the United States; however, it remains poorly characterized in surgical populations. To better inform perioperative transfusion practice, and to help mitigate perioperative TRALI, the authors aimed to better define its epidemiology before and after TRALI mitigation strategies were introduced. METHODS: This retrospective cohort study examined outcomes of adult patients undergoing noncardiac surgery with general anesthesia who received intraoperative transfusions during 2004 (n = 1,817) and 2011 (n = 1,562). The demographics and clinical characteristics of transfusion recipients, blood transfusion descriptors, and combined TRALI/possible TRALI incidence rates were evaluated. Univariate analyses were used to compare associations between patient characteristics, transfusion details, and TRALI mitigation strategies with TRALI/possible TRALI incidence rates in a before-and-after study design. RESULTS: The incidence of TRALI/possible TRALI was 1.3% (23 of 1,613) in 2004 versus 1.4% (22 of 1,562) in 2011 (P = 0.72), with comparable overall rates in males versus females (1.4% [23 of 1,613] vs. 1.2% [22 of 1,766]) (P = 0.65). Overall, thoracic (3.0% [4 of 133]), vascular (2.7% [10 of 375]), and transplant surgeries (2.2% [4 of 178]) carried the highest rates of TRALI/possible TRALI. Obstetric and gynecologic surgical patients had no TRALI episodes. TRALI/possible TRALI incidence increased with larger volumes of blood product transfused (P < 0.001). CONCLUSIONS: Perioperative TRALI/possible TRALI is more common than previously reported and its risk increases with greater volumes of blood component therapies. No significant reduction in the combined incidence of TRALI/possible TRALI occurred between 2004 and 2011, despite the introduction of TRALI mitigation strategies. Future efforts to identify specific risk factors for TRALI/possible TRALI in surgical populations may reduce the burden of this life-threatening complication.
BACKGROUND: Transfusion-related acute lung injury (TRALI) is the leading cause of transfusion-related death in the United States; however, it remains poorly characterized in surgical populations. To better inform perioperative transfusion practice, and to help mitigate perioperative TRALI, the authors aimed to better define its epidemiology before and after TRALI mitigation strategies were introduced. METHODS: This retrospective cohort study examined outcomes of adult patients undergoing noncardiac surgery with general anesthesia who received intraoperative transfusions during 2004 (n = 1,817) and 2011 (n = 1,562). The demographics and clinical characteristics of transfusion recipients, blood transfusion descriptors, and combined TRALI/possible TRALI incidence rates were evaluated. Univariate analyses were used to compare associations between patient characteristics, transfusion details, and TRALI mitigation strategies with TRALI/possible TRALI incidence rates in a before-and-after study design. RESULTS: The incidence of TRALI/possible TRALI was 1.3% (23 of 1,613) in 2004 versus 1.4% (22 of 1,562) in 2011 (P = 0.72), with comparable overall rates in males versus females (1.4% [23 of 1,613] vs. 1.2% [22 of 1,766]) (P = 0.65). Overall, thoracic (3.0% [4 of 133]), vascular (2.7% [10 of 375]), and transplant surgeries (2.2% [4 of 178]) carried the highest rates of TRALI/possible TRALI. Obstetric and gynecologic surgical patients had no TRALI episodes. TRALI/possible TRALI incidence increased with larger volumes of blood product transfused (P < 0.001). CONCLUSIONS: Perioperative TRALI/possible TRALI is more common than previously reported and its risk increases with greater volumes of blood component therapies. No significant reduction in the combined incidence of TRALI/possible TRALI occurred between 2004 and 2011, despite the introduction of TRALI mitigation strategies. Future efforts to identify specific risk factors for TRALI/possible TRALI in surgical populations may reduce the burden of this life-threatening complication.
Authors: Ognjen Gajic; Ousama Dabbagh; Pauline K Park; Adebola Adesanya; Steven Y Chang; Peter Hou; Harry Anderson; J Jason Hoth; Mark E Mikkelsen; Nina T Gentile; Michelle N Gong; Daniel Talmor; Ednan Bajwa; Timothy R Watkins; Emir Festic; Murat Yilmaz; Remzi Iscimen; David A Kaufman; Annette M Esper; Ruxana Sadikot; Ivor Douglas; Jonathan Sevransky; Michael Malinchoc Journal: Am J Respir Crit Care Med Date: 2010-08-27 Impact factor: 21.405
Authors: Guergana K Savova; James J Masanz; Philip V Ogren; Jiaping Zheng; Sunghwan Sohn; Karin C Kipper-Schuler; Christopher G Chute Journal: J Am Med Inform Assoc Date: 2010 Sep-Oct Impact factor: 4.497
Authors: Catherine Plaisant; Stanley Lam; Stanley J Lam; Ben Shneiderman; Mark S Smith; David Roseman; David H Roseman; Greg Marchand; Michael Gillam; Craig Feied; Jonathan Handler; Hank Rappaport Journal: AMIA Annu Symp Proc Date: 2008-11-06
Authors: Neil Blumberg; Joanna M Heal; Kelly F Gettings; Richard P Phipps; Debra Masel; Majed A Refaai; Scott A Kirkley; L Benjamin Fialkow Journal: Transfusion Date: 2010-12 Impact factor: 3.157
Authors: Alexander P J Vlaar; Jorrit J Hofstra; Rogier M Determann; Denise P Veelo; Frederique Paulus; Wim Kulik; Johanna Korevaar; Bas A de Mol; Marianne M W Koopman; Leendert Porcelijn; Jan M Binnekade; Margreeth B Vroom; Marcus J Schultz; Nicole P Juffermans Journal: Blood Date: 2011-02-16 Impact factor: 22.113
Authors: Christopher C Silliman; Lynn K Boshkov; Zahra Mehdizadehkashi; David J Elzi; William O Dickey; Linda Podlosky; Gwen Clarke; Daniel R Ambruso Journal: Blood Date: 2002-09-05 Impact factor: 22.113
Authors: Nareg H Roubinian; Mark R Looney; Sheila Keating; Daryl J Kor; Clifford A Lowell; Ognjen Gajic; Rolf Hubmayr; Michael Gropper; Monique Koenigsberg; Gregory A Wilson; Michael A Matthay; Pearl Toy; Edward L Murphy Journal: Transfusion Date: 2017-05-03 Impact factor: 3.157
Authors: Junghyun Kim; Trang T T Nguyen; Yue Li; Chen-Ou Zhang; Boyoung Cha; Yunbo Ke; Michael A Mazzeffi; Kenichi A Tanaka; Anna A Birukova; Konstantin G Birukov Journal: Am J Physiol Lung Cell Mol Physiol Date: 2020-01-08 Impact factor: 5.464
Authors: Matthew A Warner; Kalli K Schaefer; Nageswar Madde; Jennifer M Burt; Andrew A Higgins; Daryl J Kor Journal: Transfusion Date: 2019-04-19 Impact factor: 3.157
Authors: Mark M Smith; Daryl J Kor; Ryan D Frank; Timothy J Weister; Joseph A Dearani; Matthew A Warner Journal: J Cardiothorac Vasc Anesth Date: 2020-01-07 Impact factor: 2.628
Authors: Matthew A Warner; Ryan D Frank; Timothy J Weister; Mark M Smith; James R Stubbs; Daryl J Kor Journal: Transfusion Date: 2018-11-01 Impact factor: 3.157